UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 260

Sortiert nach

Will risk compensation accompany pre-exposure prophylaxis for HIV?

The Virtual mentor, 2014-11, Vol.16 (11), p.909

2014

Link zum Volltext

Verfügbarkeit prüfen

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens

PloS one, 2020-01, Vol.15 (1), p.e0224875-e0224875

2020

Link zum Volltext

Verfügbarkeit prüfen

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

AIDS (London), 2009-06, Vol.23 (9), p.1109-1118

2009

Link zum Volltext

Verfügbarkeit prüfen

Reply to Pandita et al

Clinical infectious diseases, 2021-07, Vol.73 (2), p.357-357

2021

Link zum Volltext

Verfügbarkeit prüfen

Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection

PLoS pathogens, 2014-01, Vol.10 (1), p.e1003853-e1003853

2014

Link zum Volltext

Verfügbarkeit prüfen

Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners

PloS one, 2019-12, Vol.14 (12), p.e0226160

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

AIDS (London), 2009-11, Vol.23 (17), p.2289-2300

2009

Link zum Volltext

Verfügbarkeit prüfen

Pilot comparison of the ease of swallowing of single tablet antiretroviral regimens

AIDS care, 2022-03, Vol.34 (3), p.404-407

2022

Link zum Volltext

Verfügbarkeit prüfen

Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment

Journal of virology, 2014-07, Vol.88 (14), p.7818-7827

2014

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of and risk factors for Human Immunodeficiency Virus (HIV) infection in entrants and residents of an Ethiopian prison

PloS one, 2023-02, Vol.18 (2), p.e0271666-e0271666

2023

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder

Clinical infectious diseases, 2014-04, Vol.58 (7), p.1015-1022

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2007-07, Vol.370 (9581), p.29-38

2007

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Drug Resistance in HIV-1–Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy

The Journal of infectious diseases, 2011-08, Vol.204 (4), p.515-520

2011

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Therapy in the Elite Controller: Justified or Premature?

The Journal of infectious diseases, 2015-06, Vol.211 (11), p.1689-1691

2015

Link zum Volltext

Verfügbarkeit prüfen

Shedding of HIV and Human Herpesviruses in the Semen of Effectively Treated HIV-1—Infected Men Who Have Sex With Men

Clinical infectious diseases, 2013-08, Vol.57 (3), p.441-447

2013

Link zum Volltext

Verfügbarkeit prüfen

Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men

PloS one, 2015-06, Vol.10 (6), p.e0130410-e0130410

2015

Link zum Volltext

Verfügbarkeit prüfen

Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1

Journal of Virology, 2012-12, Vol.86 (24), p.13202-13216

2012

Link zum Volltext

Verfügbarkeit prüfen

Transmitted drug resistance in the CFAR network of integrated clinical systems cohort: prevalence and effects on pre-therapy CD4 and viral load

PloS one, 2011-06, Vol.6 (6), p.e21189-e21189

2011

Link zum Volltext

Verfügbarkeit prüfen

HIV Viremia and Incidence of Non-Hodgkin Lymphoma in Patients Successfully Treated With Antiretroviral Therapy

Clinical infectious diseases, 2014-06, Vol.58 (11), p.1599-1606

2014

Link zum Volltext

Verfügbarkeit prüfen

Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy

Scientific reports, 2015-08, Vol.5 (1), p.13179-13179, Article 13179

2015

Link zum Volltext

Verfügbarkeit prüfen

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins

PloS one, 2009-08, Vol.4 (8), p.e6687-e6687

2009

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of Total, Linear Nonintegrated, and Integrated HIV-1 DNA In Vivo and In Vitro

The Journal of infectious diseases, 2008-02, Vol.197 (3), p.411-419

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 260

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(207)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(257)
Japanisch
(16)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(175)
Life Sciences & Biomedicine
(154)
Humans
(146)
Infectious Diseases
(128)
Male
(102)
Hiv Infections - Drug Therapy
(98)
Hiv
(93)
Adult
(91)
Immunology
(87)
Female
(85)
Biological And Medical Sciences
(80)
Human Immunodeficiency Virus
(78)
Medical Sciences
(76)
Middle Aged
(60)
Microbiology
(57)
Virology
(56)
Antiviral Agents
(50)
Human Viral Diseases
(50)
Viral Diseases
(50)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(47)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

Will risk compensation accompany pre-exposure prophylaxis for HIV?

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

Reply to Pandita et al

Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

Pilot comparison of the ease of swallowing of single tablet antiretroviral regimens

Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment

Prevalence of and risk factors for Human Immunodeficiency Virus (HIV) infection in entrants and residents of an Ethiopian prison

Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

Antiretroviral Drug Resistance in HIV-1–Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy

Antiretroviral Therapy in the Elite Controller: Justified or Premature?

Shedding of HIV and Human Herpesviruses in the Semen of Effectively Treated HIV-1—Infected Men Who Have Sex With Men

Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men

Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen

Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1

Transmitted drug resistance in the CFAR network of integrated clinical systems cohort: prevalence and effects on pre-therapy CD4 and viral load

HIV Viremia and Incidence of Non-Hodgkin Lymphoma in Patients Successfully Treated With Antiretroviral Therapy

Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins

Dynamics of Total, Linear Nonintegrated, and Integrated HIV-1 DNA In Vivo and In Vitro

Suchergebnisse filtern